Evidence map›Paper›PMID 38375209›Full record

ArticleFrontiers in pharmacology2023

Scaling up production of recombinant human basic fibroblast growth factor in an

Le Li, Bingjie Yu, Yingji Lai, Siyuan Shen, Yawei Yan, Guojun Dong, Xiangyun Gao, Yanrong Cao, Caojie Ge, Liqin Zhu and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Le Li *School of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Bingjie Yu *School of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Yingji Lai *Alberta Institute, Wenzhou Medical University, Wenzhou, China.
Siyuan ShenSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Yawei YanSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Guojun DongSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Xiangyun GaoSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Yanrong CaoSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Caojie GeSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Liqin ZhuSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Huan LiuSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Shanhui TaoInstitute of Life Science, Wenzhou University, Wenzhou, China.
Zhiang YaoInstitute of Life Science, Wenzhou University, Wenzhou, China.
Shijun LiInstitute of Life Science, Wenzhou University, Wenzhou, China.
Xiaojie WangSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.
Qi HuiSchool of Pharmacy, Wenzhou Medical University, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

500-L fermentationEscherichia coli BL21(DE3) plysShbFGFoptimized productionpurificationwound healing

Identifiers

PMID38375209
PMCPMC10875678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.